Symbiotic Therapeutics Private Limited

Symbiotic Therapeutics Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U51109DL2000PTC106441 Incorporated 23 June 2000 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company pharma MSME · Small
Revenue · FY 2026
₹29.86 Cr
▲ 13% YoY
Net profit · FY 2026
₹1.67 Cr
Net margin 5.6%
EBITDA · FY 2026
₹2.47 Cr
EBITDA margin 8.3%
Authorised capital
₹30 Lakh
Registered with MCA
Paid-up capital
₹30 Lakh
Issued & subscribed
Open charges
₹95 Lakh
Satisfied ₹2.2 Cr
Company age
26 yrs
Est. 2000
Employees · EPFO
184
Provident fund records

About Symbiotic Therapeutics Private Limited

Data last updated:

Symbiotic Therapeutics Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 June 2000 and has been in existence for over 26 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51109DL2000PTC106441. Its GSTIN is 02AAECS8069A1ZN (Himachal Pradesh). The company holds 3 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹30 Lakh. It was formerly known as Symbiotic Drugs & Diabetic Care Private Limited. It is led by directors Bhupender Kaushal and Sanjay Guleria.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 305 Mahajan Tower Plot No 7 L.Sc Shreshtha Vihar, New Delhi, Delhi, India – 110092.

As per the financials filed for FY 2026, the company reported a revenue of ₹29.86 Cr, a growth of 13% compared to the previous year. For the same year it recorded a net profit of ₹1.67 Cr (net margin 5.6%) and EBITDA of ₹2.47 Cr (EBITDA margin 8.3%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 11% over five years.

The company has about 184 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹95 Lakh and satisfied charges of ₹2.2 Cr on record. Court records list 4 cases involving the company, including 4 filed by the company; 2 cases are pending.

Symbiotic Therapeutics Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HP-11-0002572). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website symbiotictherapeutics.com.

Company details

CIN U51109DL2000PTC106441
Registration Number 106441
Incorporation Date 23 June 2000
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-HP-11-0002572

Recognitions & Rankings of Symbiotic Therapeutics

MSME (Udyam registered) Ministry of MSME
Category
Small (2023-24)
Udyam number
UDYAM-HP-11-0002572

Contact details

Symbiotic Therapeutics Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    305 Mahajan Tower Plot No 7 L.Sc Shreshtha Vihar, New Delhi, Delhi, India – 110092
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Symbiotic Therapeutics Private Limited, buy the company report.

Comprehensive company report
Symbiotic Therapeutics Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Symbiotic Therapeutics is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturing21Manufacture of basic pharmaceutical products and pharmaceutical preparations

To see the full business activity and turnover split of Symbiotic Therapeutics Private Limited, buy the company report.

Financials of Symbiotic Therapeutics Private Limited

FY 2026 filings available

Symbiotic Therapeutics Private Limited reported revenue of ₹29.86 Cr (up 13% YoY) for FY 2026.

Revenue · FY 2026
₹29.86 Cr ▲ 13%
Net profit · FY 2026
₹1.67 Cr margin 5.6%
EBITDA · FY 2026
₹2.47 Cr margin 8.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 13%
3 years · compounded
▲ 6%
5 years · compounded
▲ 11%
EBITDA CAGR growth
1 year
▲ 46%
3 years · compounded
▼ 9%
5 years · compounded
▲ 3%

Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 13% growth in the latest year. EBITDA rose 46% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹29.86 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹2.47 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1.67 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin8.3%
Net Profit Margin5.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Symbiotic Therapeutics Private Limited, buy the company report.

Board of directors of Symbiotic Therapeutics Private Limited

Symbiotic Therapeutics has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Bhupender KaushalDirector23 Jun 200026 Years 4 MonthsCurrent
Sanjay GuleriaDirector23 Jun 200026 Years 4 MonthsCurrent

Auditor

Symbiotic Therapeutics Private Limited is audited by NAVEEN KUMAR & ASSOCIATES for the financial year 2026.

Auditor firmFinancial yearFirm registration number
NAVEEN KUMAR & ASSOCIATESFY 2026006322C

Shareholding

The shareholding of Symbiotic Therapeutics Private Limited is on record for 5 financial years, the latest being FY 2026, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2026FY 2025FY 2024FY 2023FY 2022
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Symbiotic Therapeutics Private Limited, buy the company report.

Charges & borrowings

Open charges
₹95 Lakh
Satisfied charges
₹2.2 Cr
Breakdown by lending institutions
Punjab National Bank₹0.95 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
20 Apr 200590059057Punjab National Bank₹95 LakhOpen
20 Jun 2019100271363Others₹25 LakhSatisfied
26 Oct 2018100224139Others₹10 LakhSatisfied
30 Jan 201310402647Punjab National Bank₹8.5 LakhSatisfied
08 Aug 200810117355Member Secretary₹15.09 LakhSatisfied

To see the full charge records of Symbiotic Therapeutics Private Limited, buy the company report.

Total charge records: 9 View all charges

Credit ratings & regulatory alerts

Symbiotic Therapeutics Private Limited was last rated by Crisil on 14 Jun 2020.

Rating agencyRated onRating
Crisil14 Jun 2020

To see the full credit ratings and regulatory alerts of Symbiotic Therapeutics Private Limited, buy the company report.

MSME payment delays

Symbiotic Therapeutics Private Limited has 13 MSME Form 1 returns on record between 2019 and 2023, listing 708 overdue payments to 27 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 27)

SupplierAmount dueDue sinceReported on
Alex Packaging Private Limited
Sunplen Packaging
Symbiosis Pharmaceuticals Private Limited
MDC Pharmaceuticals Limited
Nav Foils Pak

To see the full MSME payment records of Symbiotic Therapeutics Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Symbiotic Therapeutics Private Limited has a workforce of 184 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
184
Active EPFO establishments
1
Employee growth
15%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-27184
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Symbiotic Therapeutics Private Limited, buy the company report.

GST

Symbiotic Therapeutics has 3 GST registrations: 1 active and 2 cancelled or inactive.

Total GSTINs
3
Active
1
Cancelled / inactive
2
GSTINStateStatusRegistered on
02AAECS8069A1ZNHimachal PradeshActive01 Jul 2017

To see the full GST registrations and return filing status of Symbiotic Therapeutics Private Limited, buy the company report.

Recent activity

Symbiotic Therapeutics Private Limited has 4 board changes on record since 2000: 2 appointments and 2 cessations. The latest: Babita Guleria ceased to be Director on 01 Aug 2009.

Filing
Symbiotic Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Delhi.
AGM
Symbiotic Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge registered on 26 Oct 2018 via Charge ID 100224139 with Others was fully satisfied on 21 Oct 2024.
Charges
A charge registered on 20 Jun 2019 via Charge ID 100271363 with Others was fully satisfied on 16 Oct 2024.
Charges
A charge registered on 30 Jan 2013 via Charge ID 10402647 with Punjab National Bank was fully satisfied on 29 Jul 2019.
Charges
A charge with Others amounted to Rs. 25.00 Lakh with Charge ID 100271363 was registered on 20 Jun 2019.
Charges
A charge registered on 08 Aug 2008 via Charge ID 10117355 with Member Secretary was fully satisfied on 26 Mar 2019.
Charges
A charge with Others amounted to Rs. 10.00 Lakh with Charge ID 100224139 was registered on 26 Oct 2018.
Charges
A charge with Punjab National Bank amounted to Rs. 8.50 Lakh with Charge ID 10402647 was registered on 30 Jan 2013.
Charges
A charge registered on 20 Apr 2005 via Charge ID 80060507 with Punjab National Bank was fully satisfied on 18 Aug 2010.
Charges
A charge registered on 13 Feb 2007 via Charge ID 10038993 with Punjab National Bank was fully satisfied on 21 May 2010.
Charges
A charge registered on 10 Jan 2007 via Charge ID 10038402 with Punjab National Bank was fully satisfied on 21 May 2010.

13 earlier events are in the company report.

Frequently asked questions

Symbiotic Therapeutics is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 June 2000 (26+ years old) and is registered under CIN U51109DL2000PTC106441.

Symbiotic Therapeutics has 2 current directors:

The latest financial statements of Symbiotic Therapeutics on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Symbiotic Therapeutics is 02AAECS8069A1ZN, registered in Himachal Pradesh. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.

The CIN (Corporate Identification Number) of Symbiotic Therapeutics is U51109DL2000PTC106441. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Symbiotic Therapeutics has 4 court cases on record: 4 filed by the company. 2 are pending.

Symbiotic Therapeutics was incorporated on 23 June 2000, making it 26+ years old. It is registered with the Registrar of Companies, Delhi.

Babita Guleria ceased to be Director on 01 Aug 2009. Kalpana Kaushal ceased to be Director on 01 Aug 2009. Bhupender Kaushal was appointed as Director on 23 Jun 2000. Symbiotic Therapeutics has 4 board changes on record in total.

Yes, Symbiotic Therapeutics is registered as a small enterprise under Udyam registration (number: UDYAM-HP-11-0002572).

Symbiotic Therapeutics has 13 MSME Form 1 returns on record between 2019 and 2023, listing 708 overdue payments to 27 micro and small suppliers. The latest return was filed on 04 Jan 2024.

Symbiotic Therapeutics can be reached through the website symbiotictherapeutics.com. Its registered office is in New Delhi, Delhi, India.